ACX
The Compounding Loophole
Scott Alexander examines how compounding pharmacies are producing cheaper versions of GLP-1 agonist drugs, exploring the economics, safety, and future implications of this practice.
12 min read 1,780 words
A thread through the archive
Essays tagged “drug shortages”. Follow an idea across the archive.
Scott Alexander examines how compounding pharmacies are producing cheaper versions of GLP-1 agonist drugs, exploring the economics, safety, and future implications of this practice.
Scott Alexander analyzes how FDA regulations contribute to drug shortages and high prices, using buspirone and insulin as examples.